These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38810335)
1. A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments. Hefny SM; El-Moselhy TF; El-Din N; Ammara A; Angeli A; Ferraroni M; El-Dessouki AM; Shaldam MA; Yahya G; Al-Karmalawy AA; Supuran CT; Tawfik HO Eur J Med Chem; 2024 Aug; 274():116527. PubMed ID: 38810335 [TBL] [Abstract][Full Text] [Related]
2. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Petreni A; Allam RM; El Diwani HI; Supuran CT Eur J Med Chem; 2022 Jan; 228():114004. PubMed ID: 34847409 [TBL] [Abstract][Full Text] [Related]
3. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX. Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899 [TBL] [Abstract][Full Text] [Related]
4. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform. Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents. Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity. Eldehna WM; Abdelrahman MA; Nocentini A; Bua S; Al-Rashood ST; Hassan GS; Bonardi A; Almehizia AA; Alkahtani HM; Alharbi A; Gratteri P; Supuran CT Bioorg Chem; 2019 Sep; 90():103102. PubMed ID: 31299596 [TBL] [Abstract][Full Text] [Related]
7. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells. Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580 [TBL] [Abstract][Full Text] [Related]
8. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity. Soliman AM; Ghorab MM; Bua S; Supuran CT Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534 [TBL] [Abstract][Full Text] [Related]
9. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights. Abo-Ashour MF; Eldehna WM; Nocentini A; Bonardi A; Bua S; Ibrahim HS; Elaasser MM; Kryštof V; Jorda R; Gratteri P; Abou-Seri SM; Supuran CT Eur J Med Chem; 2019 Dec; 184():111768. PubMed ID: 31629164 [TBL] [Abstract][Full Text] [Related]
10. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607 [TBL] [Abstract][Full Text] [Related]
11. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394 [TBL] [Abstract][Full Text] [Related]
12. Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer. Liang Q; Zhang S; Liu J; Zhou X; Syamimi Ariffin N; Wei J; Shi C; Ma X; Zhang Y; Huang R Bioorg Chem; 2024 Sep; 150():107596. PubMed ID: 38941699 [TBL] [Abstract][Full Text] [Related]
13. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. Bonardi A; Bua S; Combs J; Lomelino C; Andring J; Osman SM; Toti A; Di Cesare Mannelli L; Gratteri P; Ghelardini C; McKenna R; Nocentini A; Supuran CT J Enzyme Inhib Med Chem; 2022 Dec; 37(1):930-939. PubMed ID: 35306936 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Szafrański K; Vullo D; Supuran CT Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761 [TBL] [Abstract][Full Text] [Related]
15. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. Elbadawi MM; Eldehna WM; Nocentini A; Abo-Ashour MF; Elkaeed EB; Abdelgawad MA; Alharbi KS; Abdel-Aziz HA; Supuran CT; Gratteri P; Al-Sanea MM Eur J Med Chem; 2021 Jun; 218():113360. PubMed ID: 33773285 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors. Al-Wahaibi LH; Youssif BGM; Taher ES; Abdelazeem AH; Abdelhamid AA; Marzouk AA Molecules; 2021 Aug; 26(16):. PubMed ID: 34443307 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular modelling and QSAR study of new Said MF; George RF; Petreni A; Supuran CT; Mohamed NM J Enzyme Inhib Med Chem; 2022 Dec; 37(1):701-717. PubMed ID: 35168458 [TBL] [Abstract][Full Text] [Related]
19. Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights. Abdelrahman MA; Eldehna WM; Nocentini A; Bua S; Al-Rashood ST; Hassan GS; Bonardi A; Almehizia AA; Alkahtani HM; Alharbi A; Gratteri P; Supuran CT Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137489 [TBL] [Abstract][Full Text] [Related]
20. Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities. An R; Lin B; Zhao S; Cao C; Wang Y; Cheng X; Liu Y; Guo M; Xu H; Wang Y; Hou Z; Guo C Bioorg Chem; 2020 Nov; 104():104347. PubMed ID: 33142414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]